biote Corp.
BTMD
$3.47
$0.041.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.04% | 12.79% | -0.18% | 4.37% | 2.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.04% | 12.79% | -0.18% | 4.37% | 2.74% |
| Cost of Revenue | 2.13% | 7.09% | -3.42% | -3.68% | -9.20% |
| Gross Profit | 12.09% | 15.36% | 1.36% | 7.98% | 9.07% |
| SG&A Expenses | 24.37% | 15.18% | 13.28% | -0.32% | 28.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.25% | 11.84% | 6.29% | -1.58% | 11.57% |
| Operating Income | -28.67% | 15.69% | -21.60% | 32.31% | -27.35% |
| Income Before Tax | -113.07% | -32.58% | 15.43% | 84.02% | -29.53% |
| Income Tax Expenses | -71.39% | -17.45% | -101.19% | 294.60% | -729.36% |
| Earnings from Continuing Operations | -71.16% | -35.56% | 21.47% | 72.89% | -5.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 105.06% | 83.86% | -86.09% | -74.43% | 61.17% |
| Net Income | -52.12% | 42.12% | -78.46% | 69.58% | 376.82% |
| EBIT | -28.67% | 15.69% | -21.60% | 32.31% | -27.35% |
| EBITDA | -23.85% | 15.64% | -19.07% | 32.74% | -28.76% |
| EPS Basic | -47.98% | 38.88% | -11.71% | 84.55% | 22.10% |
| Normalized Basic EPS | 1,271.23% | 165.20% | -49.43% | -73.25% | 98.83% |
| EPS Diluted | -17.28% | 37.50% | -11.68% | 84.62% | 341.82% |
| Normalized Diluted EPS | 1,938.46% | 164.18% | -49.43% | -73.25% | 95.78% |
| Average Basic Shares Outstanding | -7.95% | 2.34% | 59.73% | 96.88% | 290.44% |
| Average Diluted Shares Outstanding | -41.14% | 3.93% | 59.73% | 96.88% | 7.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -0.68% | 0.34% | 0.91% | -- |